HEALTH NEWS: Supercomputing made Drug R&D wisdom

2022-07-21

Biomedical industry is one of the emerging strategic industries with active innovation and far-reaching influence in the 21st century. However, the supply and demand of the health industry are tight. ···...[閱讀更多(duō)]

2022 CMAC launches Computational Medicine Forum for the first time

2022-07-21

On July 10, 2022, the 7th CMAC Annual Conference was successfully concluded in Hangzhou. CMAC organizers invited Zheyuan Science and Technology to plan the "Computational Medicine Forum: Digital ···...[閱讀更多(duō)]

ECONOMIC DAILY: New generation information technology empowers Pharmaceutical R&D

2022-07-18

In what aspects does information technology empower the biomedical industry? The reporter of Economic Daily interviewed relevant experts who participated in the Computational Medicine Forum at the rec···...[閱讀更多(duō)]

AI-Biotech: With a financing of 100 million yuan, will this AI pharmaceutical company be China's CytoReason?

2022-07-18

Recently, an AI pharmaceutical company has entered the public eye by taking nearly 100 million yuan in Series A funding.Unlike most other AI pharmaceutical companies, Phil Rivers chooses to analyze th···...[閱讀更多(duō)]

Guangming Daily: Phil Rivers can yield insights into the difficulties associated on the Pharmaceutical Industry

2022-07-15

The dividend of traditional biochemical technology in the medical field seems to have come to an end.At present, the research and development cost of a new drug is about 2.6 billion US dollars, which ···...[閱讀更多(duō)]

Phil Rivers won Series-A funding of nearly 100 million yuan

2022-07-07

Recently, Beijing Phil Rivers Technology Co., Ltd. (Phil Rivers Tech) announced that it had completed the Series-A funding. This round of financing is led by Bohong Capital and Taiya Capital, followed···...[閱讀更多(duō)]

2020CGOG | Dr. Niu Gang was invited to talk about precision medicine

2022-06-16

On June 11, 2022, at the 12th Beijing Digestive Tumor International Summit Forum and the annual meeting of China Gastrointestinal Tumor Clinical Research Cooperation Group (CGOG), Dr. Niu Gang, the co···...[閱讀更多(duō)]

BIN | Phil Rivers won the Excellent Award in the National Disruptive Technology Innovation Competition

2022-04-25

Recently, the final of the first National Disruptive Technology Innovation Competition was successfully concluded in Shenzhen. Phil Rivers Technology (Beijing) Ltd. (Phil Rivers Tech) won the award of···...[閱讀更多(duō)]

China Science Daily: Phil Rivers has developed a new scoring system for breast cancer typing based on embryonic genes

2022-01-01

Recently, EBioMedicine, a comprehensive sub journal of The Lancet, published a research result on the exploration of the etiology and scoring system of breast cancer. The research was jointly complete···...[閱讀更多(duō)]

2021DIA | Phil Rivers has been unveiled in in Shanghai

2021-04-27

From April 16 to 17, 2021, the 2021DIA Digital Clinical Trial Innovation Forum was held in Shanghai. Deputy Director of Turing Darwin Laboratory; Zhao Yu, co-founder & COO of Phil Rivers, shared h···...[閱讀更多(duō)]